BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24023766)

  • 1. Are bisphosphonates effective in the treatment of osteoarthritis pain? A meta-analysis and systematic review.
    Davis AJ; Smith TO; Hing CB; Sofat N
    PLoS One; 2013; 8(9):e72714. PubMed ID: 24023766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials.
    Vaysbrot EE; Osani MC; Musetti MC; McAlindon TE; Bannuru RR
    Osteoarthritis Cartilage; 2018 Feb; 26(2):154-164. PubMed ID: 29222056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib for osteoarthritis.
    Puljak L; Marin A; Vrdoljak D; Markotic F; Utrobicic A; Tugwell P
    Cochrane Database Syst Rev; 2017 May; 5(5):CD009865. PubMed ID: 28530031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
    Bingham CO; Buckland-Wright JC; Garnero P; Cohen SB; Dougados M; Adami S; Clauw DJ; Spector TD; Pelletier JP; Raynauld JP; Strand V; Simon LS; Meyer JM; Cline GA; Beary JF
    Arthritis Rheum; 2006 Nov; 54(11):3494-507. PubMed ID: 17075851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates therapy for osteoarthritis: a meta-analysis of randomized controlled trials.
    Xing RL; Zhao LR; Wang PM
    Springerplus; 2016; 5(1):1704. PubMed ID: 27757376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Braces and orthoses for treating osteoarthritis of the knee.
    Duivenvoorden T; Brouwer RW; van Raaij TM; Verhagen AP; Verhaar JA; Bierma-Zeinstra SM
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD004020. PubMed ID: 25773267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative.
    Laslett LL; Kingsbury SR; Hensor EM; Bowes MA; Conaghan PG
    Ann Rheum Dis; 2014 May; 73(5):824-30. PubMed ID: 23585518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005088. PubMed ID: 27760454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of platelet-rich plasma injections for the treatment of osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.
    Xiong Y; Gong C; Peng X; Liu X; Su X; Tao X; Li Y; Wen Y; Li W
    Front Med (Lausanne); 2023; 10():1204144. PubMed ID: 37441691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates in multiple myeloma: an updated network meta-analysis.
    Mhaskar R; Kumar A; Miladinovic B; Djulbegovic B
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003188. PubMed ID: 29253322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates for Paget's disease of bone in adults.
    Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of bisphosphonates in specific knee osteoarthritis subpopulations: protocol for an OA Trial Bank systematic review and individual patient data meta-analysis.
    Deveza LA; Bierma-Zeinstra SMA; van Spil WE; Oo WM; Saragiotto BT; Neogi T; van Middelkoop M; Hunter DJ
    BMJ Open; 2018 Dec; 8(12):e023889. PubMed ID: 30573485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arthroscopic lavage and debridement for osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(12):1-37. PubMed ID: 23074463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates for advanced prostate cancer.
    Macherey S; Monsef I; Jahn F; Jordan K; Yuen KK; Heidenreich A; Skoetz N
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD006250. PubMed ID: 29278410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.